FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Flunazine-s Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
INDICATION
FLUNAZINE-S Injectable Solution is indicated for the control of pyrexia associated with swine respiratory disease.
History
There is currently no drug history available for this drug.
Other Information
ANADA# 200-489, Approved by FDA
Flunazine-S Injection
(flunixin meglumine)
Injectable Solution 50 mg/mL
Veterinary
For intramuscular use in swine.
Not for use in breeding swine.
Each mL of FLUNAZINE-S Injectable Solution contains flunixin meglumine equivalent to 50 mg flunixin, 0.1 mg edetate disodium, 2.2 mg sodium formaldehyde sulfoxylate, 4.0 mg diethanolamine, 207.2 mg propylene glycol, 5.0 mg phenol as preservative, hydrochloric acid, water for injection q.s.
Sources
Flunazine-s Manufacturers
-
Bimeda, Inc. Division Of Cross Vetpharm Group
Flunazine-s | Bimeda, Inc. Division Of Cross Vetpharm Group
DOSAGE AND ADMINISTRATION
The recommended dose for swine is 2.2 mg/kg (1 mg/lb; 2 mL per 100 lbs) body weight given by a single intramuscular administration. The injection should be given only in the neck musculature with a maximum of 10 mL per site.
Note: Intramuscular injection may cause local tissue irritation and damage. In an injection-site irritation study, the tissue damage did not resolve in all animals by Day 28 post-injection. This may result in trim loss of edible tissue at slaughter.
Login To Your Free Account